Researchers have revealed new details about the CRISPR-Cas5-HNH/Cascade complex, a variant of the type I-E CRISPR-Cas system, ...
Enzyme designers in the David Baker lab at the University of Washington in Seattle, from left: Sam Pellock, Anna Lauko, Kiera ...
Using a new technology and computational method, researchers from Fred Hutch Cancer Center and The University of Texas MD Anderson Cancer Center have uncovered a biomarker capable of accurately ...
Researchers at Fred Hutch and MD Anderson discovered RNA Polymerase II on histone genes as a biomarker for cancer ...
1d
In December 2024, the Company announced a strategic restructuring of its business operations, including the potential divestiture of its DNA Tagging and Security Products and Services ("DNA Tagging") ...
Guardant Health is overcoming skepticism with new cancer tests. Learn why GH stock is a buy, with strong growth and a shift ...
STONY BROOK, NY / ACCESS Newswire / February 11, 2025 / Applied DNA Sciences, Inc. (NASDAQ:APDN) ("Applied DNA" or the "Company"), a leader in PCR-based DNA technologies, today issued a reminder to it ...
Direct chemical synthesis has been adapted to make oligonucleotides of remarkable length, including an 800 nucleotide green ...
A new blood test is designed to find mold infections deep inside the body, sparing patients from tissue biopsies.
STONY BROOK, NY / ACCESS Newswire / February 11, 2025 /Applied DNA Sciences, Inc. (NASDAQ:APDN) ("Applied DNA" or the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback